Skip to main content
SpringerLink
Log in

Use of biomarkers cost effective to determine need for prostate biopsy

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Sathianathen NJ, et al. Incorporating biomarkers into the primary prostate biopsy setting: a cost-effectiveness analysis. Journal of Urology : 12 Jun 2018. Available from: URL: http://doi.org/10.1016/j.juro.2018.06.016

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Use of biomarkers cost effective to determine need for prostate biopsy. PharmacoEcon Outcomes News 806, 32 (2018). https://doi.org/10.1007/s40274-018-5075-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5075-z

Search

Navigation